Used in pharmaceutical synthesis as an active intermediate for developing kinase inhibitors, particularly in oncology research. Its structure enables selective modification of peptide-based compounds, enhancing cellular permeability and target binding affinity. Commonly employed in the preparation of prodrugs due to its ester-activated delivery mechanism, it facilitates improved bioavailability of active agents. Also utilized in bioconjugation techniques for labeling proteins and antibodies in diagnostic applications.